Tony Goodman insider trades
Open-market stock purchases and sales by Tony Goodman, Chief Operating Officer at Adial Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 31, 2018.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -34%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 7, 2026 | ADIL Adial Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- ADIL Adial Pharmaceuticals, Inc: 1 buy, last Apr 7, 2026